PE20020277A1 - POLIMORFO 1-{6-ETOXI-5-[3-ETIL-6,7-DIHIDRO-2-(2-METOXIETIL)-7-OXO-2H-PIRAZOLO[4,3-d]PIRIMIDIN-5-IL]-3-PIRIDILSULFONIL}-4-ETILPIPERAZINA - Google Patents

POLIMORFO 1-{6-ETOXI-5-[3-ETIL-6,7-DIHIDRO-2-(2-METOXIETIL)-7-OXO-2H-PIRAZOLO[4,3-d]PIRIMIDIN-5-IL]-3-PIRIDILSULFONIL}-4-ETILPIPERAZINA

Info

Publication number
PE20020277A1
PE20020277A1 PE2001000746A PE2001000746A PE20020277A1 PE 20020277 A1 PE20020277 A1 PE 20020277A1 PE 2001000746 A PE2001000746 A PE 2001000746A PE 2001000746 A PE2001000746 A PE 2001000746A PE 20020277 A1 PE20020277 A1 PE 20020277A1
Authority
PE
Peru
Prior art keywords
metoxyethyl
ethylpiperazine
polymorph
pyrazolo
pyrimidin
Prior art date
Application number
PE2001000746A
Other languages
English (en)
Spanish (es)
Inventor
Laurence James Harris
Richard Anthony Storey
Albert Shaw Wood
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0018656A external-priority patent/GB0018656D0/en
Priority claimed from GB0106464A external-priority patent/GB0106464D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of PE20020277A1 publication Critical patent/PE20020277A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
PE2001000746A 2000-07-28 2001-07-24 POLIMORFO 1-{6-ETOXI-5-[3-ETIL-6,7-DIHIDRO-2-(2-METOXIETIL)-7-OXO-2H-PIRAZOLO[4,3-d]PIRIMIDIN-5-IL]-3-PIRIDILSULFONIL}-4-ETILPIPERAZINA PE20020277A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0018656A GB0018656D0 (en) 2000-07-28 2000-07-28 Pharmaceutically active compounds
GB0106464A GB0106464D0 (en) 2001-03-15 2001-03-15 Crystalline therapeutic agent

Publications (1)

Publication Number Publication Date
PE20020277A1 true PE20020277A1 (es) 2002-05-11

Family

ID=26244756

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001000746A PE20020277A1 (es) 2000-07-28 2001-07-24 POLIMORFO 1-{6-ETOXI-5-[3-ETIL-6,7-DIHIDRO-2-(2-METOXIETIL)-7-OXO-2H-PIRAZOLO[4,3-d]PIRIMIDIN-5-IL]-3-PIRIDILSULFONIL}-4-ETILPIPERAZINA

Country Status (45)

Country Link
EP (1) EP1305314B1 (https=)
JP (1) JP2004505087A (https=)
KR (1) KR100457937B1 (https=)
CN (1) CN1207297C (https=)
AP (1) AP1400A (https=)
AR (1) AR032628A1 (https=)
AT (1) ATE286901T1 (https=)
AU (2) AU7269001A (https=)
BG (1) BG107266A (https=)
BR (1) BR0112734A (https=)
CA (1) CA2417264C (https=)
CZ (1) CZ2003126A3 (https=)
DE (1) DE60108398T2 (https=)
DO (1) DOP2001000217A (https=)
DZ (1) DZ3364A1 (https=)
EA (1) EA004681B1 (https=)
EC (1) ECSP034454A (https=)
EE (1) EE200300045A (https=)
ES (1) ES2231521T3 (https=)
GE (1) GEP20053494B (https=)
HR (1) HRP20030061A2 (https=)
HU (1) HUP0302982A3 (https=)
IL (1) IL153226A0 (https=)
IN (1) IN2002MU01649A (https=)
IS (1) IS6626A (https=)
MA (1) MA26931A1 (https=)
MX (1) MX233602B (https=)
MY (1) MY117831A (https=)
NO (1) NO324220B1 (https=)
NZ (1) NZ523226A (https=)
OA (1) OA12337A (https=)
PA (1) PA8523501A1 (https=)
PE (1) PE20020277A1 (https=)
PH (1) PH12001001922B1 (https=)
PL (1) PL365133A1 (https=)
PT (1) PT1305314E (https=)
SK (1) SK572003A3 (https=)
SV (1) SV2001000570A (https=)
TN (1) TNSN01112A1 (https=)
TW (1) TWI285643B (https=)
UA (1) UA72631C2 (https=)
UY (1) UY26854A1 (https=)
WO (1) WO2002010171A1 (https=)
YU (1) YU4703A (https=)
ZA (1) ZA200301457B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004072079A1 (en) * 2003-02-11 2004-08-26 Pfizer Limited Hydrated and anhydrous sildenafil hemi-citrate compound
EA008596B1 (ru) 2003-04-29 2007-06-29 Пфайзер Инк. 5,7-ДИАМИНОПИРАЗОЛО[4,3-d]ПИРИМИДИНЫ, ПОЛЕЗНЫЕ ПРИ ЛЕЧЕНИИ ГИПЕРТЕНЗИИ
US7572799B2 (en) 2003-11-24 2009-08-11 Pfizer Inc Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
DE602005011784D1 (de) 2004-04-07 2009-01-29 Pfizer Pyrazoloä4,3-düpyrimidine
BRPI0609225A2 (pt) * 2005-05-12 2010-03-09 Pfizer formas cristalinas anidras de n-[1-(2-etoxietil)-5-(n-etil-n-metilamino)-7-(4-metilpiridi n-2-il-amino)-1h-pirazolo[4,3-d]pirimidina-3-carbonil] metanossulfonamida, composição farmacêutica compreendendo as mesmas e uso das mesmas

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20000712A2 (en) * 1998-04-20 2001-06-30 Pfizer PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION
TWI265925B (en) * 1999-10-11 2006-11-11 Pfizer Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them

Also Published As

Publication number Publication date
DE60108398T2 (de) 2005-12-22
CN1444585A (zh) 2003-09-24
MA26931A1 (fr) 2004-12-20
MXPA03000856A (es) 2003-06-06
PT1305314E (pt) 2005-04-29
UY26854A1 (es) 2002-02-28
ECSP034454A (es) 2003-03-10
CN1207297C (zh) 2005-06-22
CZ2003126A3 (cs) 2004-02-18
AU2001272690B2 (en) 2005-12-08
MY117831A (en) 2004-08-30
HUP0302982A3 (en) 2005-01-28
YU4703A (sh) 2006-01-16
HK1055954A1 (en) 2004-01-30
ATE286901T1 (de) 2005-01-15
ES2231521T3 (es) 2005-05-16
ZA200301457B (en) 2004-04-28
BG107266A (bg) 2003-07-31
NZ523226A (en) 2003-07-25
PH12001001922B1 (en) 2006-11-21
CA2417264A1 (en) 2002-02-07
EA004681B1 (ru) 2004-06-24
HRP20030061A2 (en) 2003-04-30
AP1400A (en) 2005-04-28
PA8523501A1 (es) 2002-10-24
WO2002010171A1 (en) 2002-02-07
BR0112734A (pt) 2004-08-10
HUP0302982A2 (hu) 2003-12-29
AR032628A1 (es) 2003-11-19
KR100457937B1 (ko) 2004-11-20
PL365133A1 (en) 2004-12-27
AP2001002234A0 (en) 2001-09-30
JP2004505087A (ja) 2004-02-19
IL153226A0 (en) 2003-07-06
DZ3364A1 (fr) 2002-02-07
SK572003A3 (en) 2004-05-04
EP1305314A1 (en) 2003-05-02
MX233602B (es) 2006-01-10
NO20030416L (no) 2003-02-05
EP1305314B1 (en) 2005-01-12
SV2001000570A (es) 2002-09-03
OA12337A (en) 2006-05-15
UA72631C2 (uk) 2005-03-15
NO324220B1 (no) 2007-09-10
TWI285643B (en) 2007-08-21
EE200300045A (et) 2004-12-15
CA2417264C (en) 2007-06-12
DOP2001000217A (es) 2002-10-30
GEP20053494B (en) 2005-04-25
NO20030416D0 (no) 2003-01-27
KR20030016430A (ko) 2003-02-26
EA200300079A1 (ru) 2003-06-26
IS6626A (is) 2002-11-18
AU7269001A (en) 2002-02-13
TNSN01112A1 (fr) 2005-11-10
DE60108398D1 (de) 2005-02-17
IN2002MU01649A (https=) 2004-12-11

Similar Documents

Publication Publication Date Title
EA200100369A1 (ru) Химиотерапия рака с помощью ацетилдиналина в комбинации с гемцитабином, кэйпцитабином или цис-платиной
NO995893D0 (no) Elektrisk drivanordning for undervanns hydrauliske brönnhodeverktöy
ATE234625T1 (de) Glp-1 zusammensetzungen mit verlängerter wirkdauer
IT8420895A0 (it) Anello di protezione per linee ditrasmissione di energia.
EA199900581A1 (ru) Производные индана или дигидроиндола
MY126559A (en) Fungicidal 2-methoxybenzophenones
AU2002331332A1 (en) Sulfonium salts as phtoinitiators for radiation curable systems
MX9808555A (https=)
DE69835773D1 (de) Wasserverträgliche energie-härtbare zusammensetzungen, die maleimidderivate enthalten
ES2191393T3 (es) Nuevos pigmentos de complejos metalicos.
DE69910639D1 (de) Ionenquelle mit breitem Ausgangstromarbeitsbereich
PE20020277A1 (es) POLIMORFO 1-{6-ETOXI-5-[3-ETIL-6,7-DIHIDRO-2-(2-METOXIETIL)-7-OXO-2H-PIRAZOLO[4,3-d]PIRIMIDIN-5-IL]-3-PIRIDILSULFONIL}-4-ETILPIPERAZINA
NO990188D0 (no) Hydraulisk undervanns kopling
EA200200545A1 (ru) Онколитические комбинации для лечения рака
ES2187565T3 (es) Alcaloides indolicos utiles como agentes antiinflamatorios.
BG101109A (bg) Пиридилтио-съединения,метод за получаването им иприложението им за борба с бактерии от рода хеликобактер
FR2677500B1 (fr) Laser raman.
ECSP045348A (es) "procedimientos de preparacion de combretastatinas"
EA200100517A1 (ru) Антагонисты 5ht1 для антидепрессантной терапии
EA200100854A1 (ru) Кальций-литические соединения
ITRC980008A0 (it) Impianto a "pozzo" per lo sfruttamento dell'energia delle onde del mare.
DE59912656D1 (de) Hydraulikaggregat
DE69907495D1 (de) (7alpha,17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5-(10)-en-20-yn-3-on als reine verbindung
BG101221A (bg) N-заместени азабициклохептанови производни, приложими като невролептици
IT1293777B1 (it) Processo per la preparazione di tetraazamacrocicli

Legal Events

Date Code Title Description
FC Refusal